Shine-On BioMedical Co.,Ltd. (TPEX:6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
66.00
-1.00 (-1.49%)
Jul 16, 2025, 12:30 PM CST
-0.75%
Market Cap3.29B
Revenue (ttm)n/a
Net Income (ttm)-118.89M
Shares Out49.80M
EPS (ttm)-2.39
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,000
Average Volume13,624
Open67.20
Previous Close67.00
Day's Range65.80 - 67.20
52-Week Range57.00 - 70.50
Beta-0.08
RSI48.17
Earnings DateAug 8, 2025

About Shine-On BioMedical

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.